Fortrea Holdings Inc. Common Stock (FTRE) is a publicly traded Healthcare sector company. As of May 21, 2026, FTRE trades at $13.70 with a market cap of $1.29B and a P/E ratio of -1.25. FTRE moved -0.15% today. Year to date, FTRE is -17.57%; over the trailing twelve months it is +192.11%. Its 52-week range spans $3.97 to $25.28. Analyst consensus is buy with an average price target of $15.58. Rallies surfaces FTRE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Fortrea Reports $660.5M Q4 Revenue, Sets $2.55B–$2.65B 2026 Revenue Guidance: Fortrea posted Q4 revenues of $660.5 million with adjusted EBITDA of $54.0 million and a 1.14x book-to-bill ratio. Full-year 2025 revenues reached $2,723.4 million with adjusted EBITDA of $189.9 million, and it guided 2026 revenues of $2.55 billion to $2.65 billion.
| Metric | Value |
|---|---|
| Price | $13.70 |
| Market Cap | $1.29B |
| P/E Ratio | -1.25 |
| EPS | $-10.81 |
| Dividend Yield | 0.00% |
| 52-Week High | $25.28 |
| 52-Week Low | $3.97 |
| Volume | 738.32K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.72B |
| Net Income | $-986.20M |
| Gross Margin | 0.00% |
10 analysts cover FTRE: 0 strong buy, 5 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $15.58.